scholarly journals Copy Number Variations in a Population-Based Study of Charcot-Marie-Tooth Disease

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Helle Høyer ◽  
Geir J. Braathen ◽  
Anette K. Eek ◽  
Gry B. N. Nordang ◽  
Camilla F. Skjelbred ◽  
...  

Copy number variations (CNVs) are important in relation to diversity and evolution but can sometimes cause disease. The most common genetic cause of the inherited peripheral neuropathy Charcot-Marie-Tooth disease is thePMP22duplication; otherwise, CNVs have been considered rare. We investigated CNVs in a population-based sample of Charcot-Marie-Tooth (CMT) families. The 81 CMT families had previously been screened for thePMP22duplication and point mutations in 51 peripheral neuropathy genes, and a genetic cause was identified in 37 CMT families (46%). Index patients from the 44 CMT families with an unknown genetic diagnosis were analysed by whole-genome array comparative genomic hybridization to investigate the entire genome for larger CNVs and multiplex ligation-dependent probe amplification to detect smaller intragenomic CNVs inMFN2andMPZ. One patient had the pathogenicPMP22duplication not detected by previous methods. Three patients had potentially pathogenic CNVs in theCNTNAP2,LAMA2, orSEMA5A, that is, genes related to neuromuscular or neurodevelopmental disease. Genotype and phenotype correlation indicated likely pathogenicity for theLAMA2CNV, whereas theCNTNAP2andSEMA5ACNVs remained potentially pathogenic. Except thePMP22duplication, disease causing CNVs are rare but may cause CMT in about 1% (95% CI 0–7%) of the Norwegian CMT families.

2009 ◽  
Vol 257 (5) ◽  
pp. 735-741 ◽  
Author(s):  
Jia Huang ◽  
Xingyao Wu ◽  
Gladys Montenegro ◽  
Justin Price ◽  
Gaofeng Wang ◽  
...  

2019 ◽  
Vol 65 (3) ◽  
pp. 313-323 ◽  
Author(s):  
J. Mortreux ◽  
J. Bacquet ◽  
A. Boyer ◽  
E. Alazard ◽  
R. Bellance ◽  
...  

2020 ◽  
Vol 21 (12) ◽  
pp. 841-851
Author(s):  
Yongzhen Chen ◽  
Fang Fang ◽  
Kelley M Kidwell ◽  
Kiran Vangipuram ◽  
Lauren A Marcath ◽  
...  

Aim: This study explored whether inherited variants in genes causing the hereditary neuropathy condition Charcot–Marie–Tooth disease are associated with sensitivity to paclitaxel-induced peripheral neuropathy (PN). Patients & methods: Hereditary neuropathy genes previously associated with risk of paclitaxel-induced PN were sequenced in paclitaxel-treated patients. Eight putative genetic predictors in five hereditary neuropathy genes ( ARHGEF10, SBF2, FGD4, FZD3 and NXN) were tested for association with PN sensitivity after accounting for systemic exposure and clinical variables. Results: FZD3 rs7833751, a proxy for rs7001034, decreased PN sensitivity (additive model, β = -0.41; 95% CI: -0.66 to -0.17; p = 0.0011). None of the other genetic predictors were associated with PN sensitivity. Conclusion: Our results support prior evidence that FZD3 rs7001034 is protective of PN and may be useful for individualizing paclitaxel treatment to prevent PN.


2020 ◽  
pp. jmedgenet-2019-106641 ◽  
Author(s):  
Michael Volodarsky ◽  
Jennifer Kerkhof ◽  
Alan Stuart ◽  
Michael Levy ◽  
Lauren I Brady ◽  
...  

Charcot-Marie-Tooth disease (CMT) is one of the most common Mendelian disorders characterised by genetic heterogeneity, progressive distal muscle weakness and atrophy, foot deformities and distal sensory loss. In this report, we describe genetic testing data including comprehensive sequencing and copy number analysis of 34 CMT-related genes in a Canadian cohort of patients with suspected CMT. We have demonstrated a notable gender testing bias, with an overall diagnostic yield of 15% in males and 21% in females. We have identified a large number of novel pathogenic variants as well as variants of unknown clinical significance in CMT-related genes. In this largest to date analysis of gene CNVs in CMT, in addition to the common PMP22 deletion/duplication, we have described a significant contribution of pathogenic CNVs in several CMT-related genes. This study significantly expand the mutational spectrum of CMT genes, while demonstrating the clinical utility of a comprehensive sequence and copy number next-generation sequencing-based clinical genetic testing in patients with suspected diagnosis of CMT.


2015 ◽  
Vol 357 (1-2) ◽  
pp. 35-40 ◽  
Author(s):  
Ganesh K. Boora ◽  
Amit A. Kulkarni ◽  
Rahul Kanwar ◽  
Peter Beyerlein ◽  
Rui Qin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document